Schedule 13D ownership disclosure
THERAVANCE BIOPHARMA INC
Security class unavailable · CUSIP: G8807B106
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 11.7900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-23-098992
- Form type
- SC 13D
- Filer
- Theravance Biopharma, Inc.
- CIK
- CIK 1583107
- Filed
- Apr 12, 2023
- Reporting period
- —
- Description
- Schedule 13D beneficial ownership